Sector
Health
1090 stories · page 39 of 55
HealthBeacon raises €25mln in Dublin IPO
The fund raise and Dublin listing comes as the company predicts a 10x rise in users over the next two years
PharmaDrug looking to develop and commercialise a range of psychedelics, cannabis and naturally-derived drugs
The company owns 80% of Pharmadrug GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification and 100% of Super Smart, a Dutch company building a modern adult-use psychedel
Pathway Health anticipates new pharmacy contracts for medical cannabis in 2022 as it prepares for Cannabis 3.0
Analysts predict that upcoming regulations would impact the current cannabis market in Canada by as much as $2.45 billion annually by 2023
Ketamine One adds Seattle location to its expanding US clinical network
The Canadian company said it will provide training, protocol development, and ongoing support for the clinic, with the “first patient treatments expected at Seattle Ketamine Infusions in early 2022”
Wellbeing Digital Sciences wants to make psychedelic treatments for mental health available across North America
With demand for mental health treatments growing in the face of the coronavirus pandemic, the company sees huge potential to address the need for services with new psychedelic therapies combined with an emphasis on technology
Pathway Health inks collaboration deal with Metro Ontario Pharmacies for medical cannabis management
It will first provide its accredited medical cannabis continuing education for pharmacists, then implement its Medical Cannabis Management System in Metro Ontario Pharmacies' pharmacy locations across Ontario
Pathway Health enters into LOI to acquire operating assets of NewLight Pain Clinic in Ontario
NewLight offers a wide range of pain management services including medical, physiotherapy, chiropractic, massage therapy and acupuncture and orthopedic devices and products that support the lifestyles of those living with chronic pain
KetamineOne subsidiary KGK Science helps its client Hofseth Biocare receive New Dietary Ingredient status from US FDA
KGK Science has successfully helped Hofseth Biocare win New Dietary Ingredient status from the US FDA for its CalGo and OmeGo nutritional supplements extracted from Norwegian Atlantic salmon
Pathway Health appoints Dr. Jimmy Nanda to lead its expansion allied health services
The Toronto-based company said that Dr. Nanda brings a wealth of experience and leadership to allied health care in North America and India
KetamineOne in partnership to launch depression and PTSD clinical studies
The protocols for both studies have received Institutional Review Board approval and patient recruitment is expected to occur in early 2022
Pathway Health and Canntab Therapeutics strike agreement to provide oral tablet cannabinoid products in select Canadian pharmacies
The products will consist of a range of both THC and CBD dosages in oral formats
Revitalist Lifestyle and Wellness is on a mission to treat mental health and chronic pain on a global scale with integrated care
Revitalist Chief Executive Officer Kathryn Walker discusses the company’s growth plans and the advantages of its business model
Irwin Naturals lists on OTCQB Venture Market under 'IWINF'
Irwin Naturals also told investors that its shares have become eligible for delivery and depository services with the Depository Trust Company
ASX recovers some losses as travel stocks crash
The UN’s tourism body has said the tourism sector’s recovery would be “fragile” and “slow”, but the pandemic would cost the global tourism sector $US2 trillion in lost revenue in 2021.
New German government set to legalise recreational cannabis
Medicinal use is already legal in many European countries
Braxia Scientific is making a scientific case for psychedelic medicine
As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics complements its sharp focus on research and development
Pathway Health reports fiscal 3Q financials showing a positive cash position of $4.2M
The integrated healthcare company reported total revenue for the three and nine months ended September 30, 2021, of $2.7 million and $8.2 million respectively
Pathway Health making progress as provider of out-of-hospital pain management services in Canada
The company’s Virtual Clinics division has the largest medical cannabis telemedicine network in Canada serving over 50,000 patients
Psychedelic companies say Compass study result validates industry's hope to find alternative treatments for mental health
Psychedelic companies feel that Compass Pathways results validate efforts to develop next-generation medicine for treating mental health issues